Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Starton Therapeutics to Present at Upcoming MedInvest and Needham Conferences | ||
By: GlobeNewswire - 25 Mar 2024 | Back to overview list |
|
PARAMUS, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc., (“Starton” or the “Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, today announced that Pedro Lichtinger, Chairman and Chief Executive Officer of Starton Therapeutics, will present and host one-on-one meetings at the MedInvest Biotech & Pharma Investor and 23rd Annual Needham Virtual Healthcare Conferences. Details for the events are as follows: MedInvest Biotech & Pharma Investor Conference 23rd Annual Needham Virtual Healthcare Conference About Starton Therapeutics Forward-Looking Statements Investor Relations: |
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |